| MR编号 | SI/H/0266/001 |
|---|
| 药品名称 | Tigecycline AptaPharma 50 mg powder for solution for infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Powder for solution for infusion |
|---|
| 上市许可持有人 | Apta Medica Internacional Družba Za Trženje Farmacevtskih Izdelkov In Medicinskih Pripomočkov d.o.o.
Likozarjeva Ulica 6,
1000 Ljubljana,
Slovenia |
|---|
| 参考成员国 - 产品名称 | Slovenia (SI) Tigeciklin AptaPharma 50 mg prašek za raztopino za infundiranje |
|---|
| 互认成员国 - 产品名称 | - Czechia (CZ)
Tigecycline AptaPharma - Romania (RO)
Tigeciclină AptaPharma 50 mg pulbere pentru soluție perfuzabilă - Slovakia (SK)
- Malta (MT)
Tigecycline AptaPharma 50 mg powder for solution for infusion - Croatia (HR)
- Austria (AT)
- Poland (PL)
Tigecycline AptaPharm - Hungary (HU)
- Bulgaria (BG)
Tigecycline AptaPharma - Cyprus (CY)
Tigecycline AptaPharma 50 mg κόνις για διάλυμα προς έγχυση
|
|---|
| 许可日期 | 2024/03/07 |
|---|
| 最近更新日期 | 2025/06/12 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|